Background. Quantitative sensory testing (QST) has been used to predict the outcome of epidural steroid injections in lumbosacral radicular pain and has the potential to be an important tool in the selection of appropriate treatment (such as epidural steroid injections vs surgery) for patients with chronic radicular pain. In addition, QST assists in identification of the pain pathways of peripheral and central sensitization in selected groups of patients. Methods. Twenty-three patients were given dorsal root ganglion (DRG) infiltration with local anaesthesia and steroid ('DRG block'), and those who demonstrated at least 50% pain relief were offered pulsed radiofrequency (PRF) to the DRG. Questionnaires and QST scores were measured before the DRG blocks and at 1 week and 3 months after their procedure. Those who received PRF also answered questionnaires and underwent QST measurements at 1 week and 3 months after their procedure.
in quality, and may have a cutaneous element. The pathophysiology of chronic lumbar radicular pain involves mechanical, inflammatory, and immunological factors that affect the function of the dorsal root ganglion (DRG). 2 Although both mechanical compression to the nerve root and associated inflammatory changes have been implicated in the pathogenesis of lumbar radicular pain, it is difficult to predict the dominant contributory factor in any particular individual. Animal studies have shown that injury can cause spontaneous and enhanced DRG activity. 3 In addition, inflammatory mediators released at the site of the herniated disc can alter sodium, potassium, and calcium ion channels on the DRG surface, causing ectopic and sustained firing. 4 Such sustained DRG discharges have been linked to sensitization of the spinal dorsal horn cells and the resulting state of hyperalgesia. 5 Based on these observations, the DRG is considered to be the most likely focus of ectopic impulse origin in patients with radicular pain and the prime target for neurodestructive and neuromodulator pain treatments. 6 Injection of steroid into the epidural space for the treatment of radicular pain does not always relieve pain. 7 One alternative is the use of pulsed radiofrequency (PRF) to the DRG. Unlike conventional radiofrequency ablation, where a high-frequency alternating current is used to produce non-selective coagulative necrosis by heating target tissue, PRF uses short, high-voltage bursts of current followed by a silent phase, allowing for heat dissemination and a controlled target temperature of 42 C.
Although the exact mechanism of action of PRF in pain relief remains poorly understood, proposed mechanisms for pain relief after PRF to the DRG include the interruption of afferent nociceptor impulses from the alteration of gene expression within the dorsal horn, 8 neuromodulation of synaptic transmission, 9 10 and suggestions that there is further disturbance with the opioid system, noradrenaline and serotonin pathways, and microglia. 11 Despite its relatively widespread use in the treatment of a variety of pain symptoms, there is a lack of welldesigned randomized controlled trials to assess its efficacy. However, case series and individual case reports have confirmed the success and excellent safety profile of PRF in managing radicular pain refractory to appropriate pharmacological and physical interventions. [12] [13] [14] [15] Quantitative sensory testing (QST) is used to describe different types of psychophysical testing of skin, mucosa, or muscle tissue that assess sensory and pain perception pathways. Various forms of QST have been described, which include methods of sensory and pain detection threshold determination under different testing paradigms. 16 Nociceptive inputs can trigger a prolonged but reversible increase in the excitability and synaptic efficacy of neurones in central nociceptive pathways, resulting in central sensitization; this may manifest as pain hypersensitivity, in particular dynamic tactile allodynia, secondary punctate or pressure hyperalgesia, and enhanced temporal summation. Central sensitization is a hyperexcitability state in nociceptive pathways and has been suggested to be the main cause of chronic pain conditions. The descending pain inhibitory system may be inhibited or facilitated by pain and conditioned pain modulation (CPM). Conditioned pain modulation refers to the phenomenon of one noxious stimulus inhibiting the sensation of a second stimulus administered remotely from the first or 'pain inhibits pain' phenomenon. 17 Quantitative sensory testing has been used to measure thresholds for different sensations in neuropathic pain (NP), reflecting the possible nerve fibres that may be implicated in the pathogenesis. The degree of dysfunction of the individual fibre types measured by the QST may identify the dominant mechanism of injury (compression vs inflammation) in patients with chronic lower radicular (CLR) pain. 18 For example, compression from a herniated disc can affect Ab-fibre function, which can be measured in experimental conditions using QST. It can therefore be proposed that QST has the potential to identify the dominant cause of CLR in patients with disc herniation. Quantitative sensory testing has been used to predict the outcome of epidural steroid injections in lumbosacral radicular pain and has the potential to be an important tool in the selection of the appropriate treatment (such as epidural steroid injections vs surgery) for patients with CLR, in addition to its role in identifying the mechanisms of pain generation in these patients. 19 A number of studies have demonstrated selective nerve fibre dysfunction in CLR using QST techniques. [20] [21] [22] [23] One study describes a correlation between QST findings and clinical outcome after disc surgery in patients with CLR; 24 another study reports on the usefulness of current perception threshold testing in assessing lower extremity sensory functions before and after surgery for lumbar disc herniation. However, the characterization of peripheral and central sensitization after DRG interventions has not yet been studied, and the role of QST as a possible predictor of the outcome after PRF to the DRG remains to be identified. This is a pilot study characterizing the response to DRG interventions using QST. The aim of the study was to investigate whether there were any changes in QST measurements, specifically peripheral and central sensitization, after DRG injections and the infiltration of the relevant dorsal root with local anaesthetic and steroid, and after PRF.
Methods

Study design
This was a single-centre, prospective study carried out at the Pain and Anaesthesia Research Centre at St Bartholomew's Hospital, Barts Health NHS Trust London, UK. The study was approved by the local ethics committee (approval 10/H070/62) and was conducted in accordance with the Declaration of Helsinki, with written informed consent obtained from the participants. There was no external funding or conflicts of interest within the team.
Participants
The study population was identified from the chronic pain clinic at St Bartholomew's Hospital, Barts Health NHS Trust in London, UK. All participants had a history of unilateral lumbar radicular pain of >6 months' duration and disc herniation confirmed on imaging studies, such as computed tomography or Editor's key points
• The authors conducted a pilot study (n¼23) of the effect of dorsal root ganglion infiltration, followed, where suitable pain relief had been demonstrated, by pulsed radiofrequency treatment.
• They used quantitative sensory testing before and after dorsal root ganglion treatments, demonstrating observable effects on components of quantitative sensory testing, consistent with normalization of pain sensitization. magnetic resonance imaging. Participants were assessed by the Principal Investigator (VM) in the pain clinic to correlate the history and examination with the findings on imaging; for example, a participant with pain radiating to the leg with a magnetic resonance imaging finding of disc herniation in contact with a nerve root on the same side and level corresponding to the pain distribution would be considered for inclusion. This patient selection was made in order to study a uniform patient population ( Fig. 1) .
Twenty-three patients were initially offered infiltration around the DRG ('DRG block') with local anaesthesia and steroid, and those who demonstrated a successful response (defined as !50% pain relief compared with baseline on a visual analog scale) were offered PRF to the DRG at the end of the 3 month follow-up period. After informed consent, twenty-three participants (13 female and 10 male), mean age 46 yr, were recruited to undergo the DRG block, and of these, 10 patients went on to receive PRF. Baseline QST measurements and questionnaires were performed before the injections and repeated after 1 week and 3 months. Eligible participants then received PRF to the DRG and QST measurements and questionnaires repeated after 1 week and 3 months. All QST measurements were made by a single, trained operator (T.W.) to ensure consistency and reproducibility of the results. For the control group, we used previously published QST data from our group 25 comprising 21 healthy, pain-free volunteers to compare with the patient groups at baseline.
Treatment procedures
All interventional pain procedures were performed under multiplane fluoroscopic guidance with a single operator (V.M.) to reduce bias. I.V. access was secured to administer conscious sedation and analgesia with midazolam 0.5-1 mg boluses and alfentanil 250-500 lg boluses as necessary. Local anaesthesia to the skin entry site was provided with lidocaine 1% infiltration. The participants were awake during the entire procedure and able to respond to dorsal root stimulation.
Dorsal root ganglion infiltration with local anaesthetic and steroid
The DRG block was performed to a standard local protocol, with a mixture of bupivacaine 0.25% 1 ml and methylprednisolone (as Depo-Medrone V R ) 20 mg injected at the site of the DRG. A radiculogram was obtained to confirm the appropriate placement, using fluoroscopy and injection of a small volume of radioopaque contrast medium (Fig. 2) .
Pulsed radiofrequency treatment
Participants who demonstrated a successful response to the DRG block (!50% pain relief compared with baseline on a visual analog scale) were offered PRF to the DRG after they had completed the 3 month follow-up questionnaires and QST measurements. Target identification and needle positioning were carried out under fluoroscopic guidance, 8 and all patients underwent sensory stimulation of the relevant DRG to confirm nerve root involvement. A Neurotherm V R radiofrequency 22 gauge 10 cm needle with 10 mm active tip was used, providing PRF to the DRG at 45 V for 180 s at 42 C. The proximity of the needle to the DRG was determined by appropriate sensory stimulation at 50 Hz (0.4-0.6 V), and motor stimulation at 2 Hz at a threshold voltage 1.5-2 times greater than that required for sensory stimulation was used to avoid placement near the anterior nerve root.
Assessments and measurements
Pressure pain thresholds
The pressure pain threshold (PPT) measures the sensitivity of peripheral pain pathways to increasing mechanical pressure. A hand-held pressure algometer (Algometer type II; Somedic Production AB, Sweden, diameter of contact tip 10 mm; cover 2 mm thick rubber; standardized and constant speed of pressure increase of 0.3 kg s
À1
) was used to measure the PPTs at four standardized points across the back on the symptomatic (maximal pain) and the contralateral side. The probe was placed perpendicular to the skin at the predefined points, and pressure was applied until the subject perceived the pressure as pain. Once this was reported, the procedure was immediately terminated. Measurements were made three times on each site, and an average PPT was used for statistical analysis.
Conditioned pain modulation
Ischaemic compression of the left arm was used as heterotopic noxious conditioning stimulation for evoking CPM. The pressure cuff was inflated above systolic pressure (200 mm Hg) for 10 min or until a visual analog scale rating of 6/10 cm was achieved, (where 0 cm represented 'no pain' and 10 cm represented 'maximal pain'). Repeat PPTs were measured on the most sensitive point on the back while the cuff was in situ. The arm cuff was released once PPT and cuff pain assessments were completed (maximum of 10 min). All QST measurements were performed by a single investigator (T.W.).
Questionnaires
The Short Form McGill Pain Questionnaire was used to describe subjective pain experience using sensory, affective, and evaluative word descriptors and numerical values. The validated 12-item short-form (SF-12) including one multi-item scale was used to assess health-related quality of life. The painDETECT screening questionnaire was used to identify neuropathic components in patients with back pain. The Hospital Anxiety and Depression Scale, consisting of seven items each for assessing clinically significant anxiety and depression, was also used.
Statistical analysis
This study is a pilot study, and no power calculations were performed. Statistical analyses were performed using Student's paired t-test or the Mann-Whitney U-test where appropriate, and are presented as means with SDs or medians with range, with significance assumed at the P<0.05 level.
Results
Dorsal root ganglion infiltration with local anaesthetic and steroid
At baseline, patients' PPTs were considerably lower than those of healthy volunteers (218.6 vs 354.5 kPa). There was a significant increase in PPT after DRG blocks (298.7 kPa after DRG block). A reduced CPM response was seen in the patient group before DRG block compared with the healthy volunteers, in whom a normal pain response was observed (patients 190.4 vs 147.5 kPa with cuff in situ; healthy volunteers 322.1 vs 445.4 kPa with cuff in situ). There was an increase in the patient group after the procedure (276.1 kPa baseline vs 399.5 kPa cuff in situ), suggesting 'normalization' of pressure pain modulation.
Pulsed radiofrequency to the DRG
Ten out of 23 patients underwent PRF to the DRG at same level (mean average 3 months) after DRG block. There was an increase in PPT after PRF (273.9 kPa before PRF vs 295.7 kPa after PRF). There was an increased CPM response after PRF (before PRF 236.3 kPa baseline vs 265.6 kPa with cuff in situ, increasing after the procedure to 250.2 kPa at baseline vs 368.6 kPa with cuff in situ), again suggesting 'normalization' of pressure pain modulation (Figs 3-5) . 
Questionnaires
The painDETECT score (Table 1) PRF, this score was reduced, with five (50%) as 'likely NP', two (20%) as 'possible NP', and three (30%) as 'unlikely NP'. There were no significant differences in anxiety or depression scores using the Hospital Anxiety and Depression Scale before or after DRG block (Table 2 ). In patients then undergoing PRF, there were again no significant differences in anxiety or depression scores after PRF, but there was a general improvement in depression scores, which did not reach significance (P¼0.07).
The Short Form McGill Pain Questionnaire scale covers the nature of pain and the quantity of pain (Table 3 ). The sensory and affective dimensions were measured on a four-point scale ranging from 0 (none), to 1 (mild), 2 (moderate), and 3 (severe). Before intervention, the subjects scored a mean of 15.7 in the sensory questions, which was significantly reduced after DRG block to a mean score of 9 (P<0.001). A significant reduction was also seen in the affective category (5.3 before DRG block vs 1.9 after block; P<0.001). In those patients who then underwent PRF, the sensory score remained a mean of 9 and in the affective category maintained an average of 2.4.
The change in outcome for SF-12 Question 1 ('In general how would you say your health is?'; Table 4 ) and Question 8 ('During the past 4 weeks how much did pain interfere with your normal work?'; Table 5 ) was significant (P<0.001) after DRG; outcomes for all other questions remained unchanged. For the PRF group, the change in outcome for SF-12 Question 1 and Question 8 was non-significant (P<0.08), and outcomes for all other questions remained unchanged.
Discussion
This pilot study shows that participants with unilateral radicular low back pain who receive a DRG infiltration with local anaesthetic and steroid and further PRF have changes in PPT and CPM that are consistent with a 'normalization' of peripheral and central sensitization.
Quantitative sensory testing is a semi-quantitative measure of large and small afferent nerve fibre function, using psychophysical tests involving the skin, mucosa, and muscle tissues.
The tests used in QST can be broadly classified as either static or dynamic measurements. Static measurements depict a single point on the pain experience continuum; for example, the threshold determination of pressure when it becomes 'painful' to the participant (PPT response), or the threshold when a subject is able to detect temperature change and it becomes painful (heat and cold temperature threshold and painful response). The static measures have the advantage of using an easily defined end point, which is stable and reproducible in practice but represents only one part of the pain process. In contrast, dynamic QST measurements may be used to capture the endogenous pain modulatory process. These measurements include tests of central integration, such as temporal and spatial summation, or tests of descending control or CPM, such as the diffuse noxious inhibitory control (DNIC) paradigm. 26 Current evidence suggests that dynamic tests can be more suitable in predicting outcomes for pain interventions. 27 Diffuse noxious inhibitory control refers to the observation that the activity of multireceptive neurones within the spinal cord can be strongly suppressed by an intense pain stimulus outside their peripheral receptive field. The response involves one of the main supraspinal pain inhibitory pathways in the central nervous system; this is known to be impaired in neuropathic pain. Induction of a DNIC response represents a neurophysiologically well-established model of endogenous pain modulation. 28 This can be measured clinically by providing a distracting but significant second stimulus, which in practice may involve the sufficient inflation of a blood pressure cuff, or immersion in ice water (cold pressor test) or hot water of a different body part from the one on which the pain perception testing is being performed. In the present study, we used an upper extremity submaximal effort tourniquet test 29 and performed PPTs with the tourniquet in situ. In a physiologically normal state, the induction of a second stimulus would increase PPT scores. In chronic pain conditions, such as fibromyalgia, the PPT scores would decrease after the second stimulus was applied, reflecting the lack of a DNIC response. 30 It can therefore be assumed that chronic pain conditions have altered peripheral and central sensitization. Dorsal root ganglion neurones express several subtypes of sodium channels that may be up-or downregulated in neuropathic pain conditions, resulting in sodium, potassium, and calcium ion current changes. 31 It has been hypothesized that electrical stimulation of the DRG (such as with PRF) may result in both upstream and downstream effects on both the unipolar cell bodies and associated satellite glial cells, which in turn stabilize peripheral nociceptor sensitization by reducing local cytokines and regulating ion channels and current flows. 6 A previous study demonstrated PRF to promote the repair and regeneration of impaired peripheral nerves. 32 In another study, PRF caused neuronal differences at targeted DRG and in neurones of the superficial dorsal horn, which may be associated with pain processing. 8 Glial cell derived neurotrophic factor (GDNF) has been demonstrated to be an important neurotrophic factor that affects neuronal survival, growth, and directed differentiation in the central and peripheral nerve system. 33 The treatment of chronic radicular pain causes a reduction in pain, which may occur from decreased neurone hyperexcitability and suppression of glial activity in the dorsal horn, 34 35 resulting in less peripheral and central sensitization.
Based on our findings, we envisage a future where it might be possible to predict the response to DRG blocks and PRF based on psychological, sensory, and sensitization profiles. This could be performed at the bedside and might allow us to predict responders to treatment. Quantitative sensory testing might allow researchers and clinicians to identify which patients are most likely to benefit from a particular intervention; at present, there is a trend towards the use of dynamic measures, such as DNIC response, to predict outcomes, whereas static measures may capture only a snapshot of the complex pain modulatory process.
In the present study, we focused on two common and wellvalidated techniques, pressure pain thresholds and the conditioned pain response. We chose this subset of QST domains because there are no published data characterizing these techniques for DRG interventions.
Large, adequately powered studies are required to answer fully the question of whether QST can be used as a test to filter out responders to treatment-this would include using a whole battery of QST-and to explore further the potential mechanisms through which DRG blocks and PRF exert their analgesic actions. In this small pilot study, we have demonstrated that QST is altered with DRG injection and PRF, suggesting that the intervention may alter sensitization in this group of patients. 
